PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9893928-0	1998	Effects of azelastine on the level of serum interleukin-4 and soluble CD23 antigen in the treatment of nasal allergy.	azelastine	11-21	Fc epsilon receptor II	Homo sapiens	70-74	
9893928-8	1998	The results show that the levels of IL-4 and soluble CD23 were significantly reduced by the administration of AZ over a 4-week period, especially in patients with "excellent" or "good" efficacy of therapy.	azelastine	110-112	Fc epsilon receptor II	Homo sapiens	53-57